223 related articles for article (PubMed ID: 22350409)
1. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.
Bosse KR; Diskin SJ; Cole KA; Wood AC; Schnepp RW; Norris G; Nguyen le B; Jagannathan J; Laquaglia M; Winter C; Diamond M; Hou C; Attiyeh EF; Mosse YP; Pineros V; Dizin E; Zhang Y; Asgharzadeh S; Seeger RC; Capasso M; Pawel BR; Devoto M; Hakonarson H; Rappaport EF; Irminger-Finger I; Maris JM
Cancer Res; 2012 Apr; 72(8):2068-78. PubMed ID: 22350409
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.
Ryser S; Dizin E; Jefford CE; Delaval B; Gagos S; Christodoulidou A; Krause KH; Birnbaum D; Irminger-Finger I
Cancer Res; 2009 Feb; 69(3):1125-34. PubMed ID: 19176389
[TBL] [Abstract][Full Text] [Related]
4. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Capasso M; Devoto M; Hou C; Asgharzadeh S; Glessner JT; Attiyeh EF; Mosse YP; Kim C; Diskin SJ; Cole KA; Bosse K; Diamond M; Laudenslager M; Winter C; Bradfield JP; Scott RH; Jagannathan J; Garris M; McConville C; London WB; Seeger RC; Grant SF; Li H; Rahman N; Rappaport E; Hakonarson H; Maris JM
Nat Genet; 2009 Jun; 41(6):718-23. PubMed ID: 19412175
[TBL] [Abstract][Full Text] [Related]
5. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract][Full Text] [Related]
6. BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women.
Śniadecki M; Brzeziński M; Darecka K; Klasa-Mazurkiewicz D; Poniewierza P; Krzeszowiec M; Kmieć N; Wydra D
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114377
[TBL] [Abstract][Full Text] [Related]
7. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.
Zhang R; Zou Y; Zhu J; Zeng X; Yang T; Wang F; He J; Xia H
Int J Med Sci; 2016; 13(2):133-8. PubMed ID: 26941572
[TBL] [Abstract][Full Text] [Related]
8. Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.
Latorre V; Diskin SJ; Diamond MA; Zhang H; Hakonarson H; Maris JM; Devoto M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):658-63. PubMed ID: 22328350
[TBL] [Abstract][Full Text] [Related]
9. BARD1 mediates TGF-β signaling in pulmonary fibrosis.
André PA; Prêle CM; Vierkotten S; Carnesecchi S; Donati Y; Chambers RC; Pache JC; Crestani B; Barazzone-Argiroffo C; Königshoff M; Laurent GJ; Irminger-Finger I
Respir Res; 2015 Sep; 16():118. PubMed ID: 26415510
[TBL] [Abstract][Full Text] [Related]
10. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
[TBL] [Abstract][Full Text] [Related]
11. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
J Natl Cancer Inst; 2024 Jan; 116(1):138-148. PubMed ID: 37688570
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
[TBL] [Abstract][Full Text] [Related]
13. BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.
Fu W; Zhu J; Xiong SW; Jia W; Zhao Z; Zhu SB; Hu JH; Wang FH; Xia H; He J; Liu GC
EBioMedicine; 2017 Feb; 16():101-105. PubMed ID: 28161399
[TBL] [Abstract][Full Text] [Related]
14. BARD1 expression during spermatogenesis is associated with apoptosis and hormonally regulated.
Feki A; Jefford CE; Durand P; Harb J; Lucas H; Krause KH; Irminger-Finger I
Biol Reprod; 2004 Nov; 71(5):1614-24. PubMed ID: 15240424
[TBL] [Abstract][Full Text] [Related]
15. Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM
Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
Pilyugin M; Irminger-Finger I
Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
18. Expression of BARD1 β Isoform in Selected Pediatric Tumors.
Jasiak A; Krawczyńska N; Iliszko M; Czarnota K; Buczkowski K; Stefanowicz J; Adamkiewicz-Drożyńska E; Cichosz G; Iżycka-Świeszewska E
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33530592
[TBL] [Abstract][Full Text] [Related]
19. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani NL; Dymek M; Desai H; Hausler R; Hicks B; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
J Natl Cancer Inst; 2024 Jan; 116(1):149-159. PubMed ID: 37688579
[TBL] [Abstract][Full Text] [Related]
20. BARD1: an independent predictor of survival in non-small cell lung cancer.
Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
